← Evidence map

ReviewDrug safety2003

Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

Jennifer Martin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this papercites it

Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant? | OpenQuestion